Insider · CIK 0002037272
Brent Sabatini
Files at VIR (Vir Biotechnology, Inc.). First filing Feb 18, 2026, latest Mar 24, 2026.
Brent Sabatini files SEC Form 4 as officer at VIR (Vir Biotechnology, Inc.). Since Feb 18, 2026, Brent Sabatini has reported 0 open-market buys worth $0 and 4 open-market sells worth $110k, the latest filed on Mar 24, 2026.
A track record needs three past buys with six months of prices behind them; Brent Sabatini has 0, so none is measured yet.
The newest scored trade: sold $70k of VIR on Mar 23, 2026, filed Mar 24, 2026, scored 16 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $110k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIR: Vir Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | Vir Biotechnology, Inc. | $70k 7,711 shares | -11% | +107% from low-12% from high | |
| 10Weak | Vir Biotechnology, Inc. | $14k 1,430 shares | -2% | +122% from low0% from high | |
| 10Weak | Vir Biotechnology, Inc. | $14k 1,829 shares | -3% | +74% from low-22% from high | |
| 10Weak | Vir Biotechnology, Inc. | $12k 1,530 shares | -3% | +75% from low-24% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | 1,562 0.00% of outstanding | $15k | Feb 24, 2025 | $14k |
| Feb 13, 2025 | VIR Vir Biotechnology, Inc. | 1,562 0.00% of outstanding | $14k | Feb 13, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -7,711 | $9.12 | $70k | 61,902 | Mar 24, 2026 |
| Feb 24, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,430 | $9.53 | $14k | 69,613 | Feb 26, 2026 |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock10b5-1 | +25,000 | $0.00 | $0 | 72,872 | Feb 24, 2026 |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,829 | $7.45 | $14k | 71,043 | Feb 24, 2026 |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +50,000 | $0.00 | $0 | 50,000 | Feb 24, 2026 |
| Feb 13, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,530 | $7.79 | $12k | 47,872 | Feb 18, 2026 |
Questions about Brent Sabatini
Answered from the filings on this page, as of the latest one.
Is Brent Sabatini buying or selling?
In the last 12 months Brent Sabatini reported 0 open-market buys worth $0 and 4 open-market sells worth $110k on SEC Form 4; the latest was sold $70k of VIR on Mar 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Brent Sabatini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brent Sabatini has 0.
Where does Brent Sabatini file Form 4?
Brent Sabatini has filed Form 4 at VIR (Vir Biotechnology, Inc.) as SVP, Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.